Patents by Inventor Steven Dinh

Steven Dinh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL DELIVERY
    Publication number: 20240122955
    Abstract: Provided herein are pharmaceutical compositions comprising therapeutic agent(s) and functional excipients that can enable oral absorption of small molecules and/or large molecules. Also provided herein are methods of preparing the pharmaceutical composition and methods of using the same for treating various diseases or disorders such as type-2 diabetes, obesity, NASH, renal disease.
    Type: Application
    Filed: December 20, 2022
    Publication date: April 18, 2024
    Inventors: Steven DINH, Huadong TANG, Wenfei LIANG
  • Compositions and kits for omeprazole suspension
    Patent number: 11911473
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Grant
    Filed: March 30, 2023
    Date of Patent: February 27, 2024
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Zeus Pendon, Steven Dinh
  • ORAL DELIVERY OF HEPARINS
    Publication number: 20230338413
    Abstract: Provided herein are pharmaceutical compositions comprising a heparin and functional excipients that can enhance oral bioavailability of the heparin. Also provided herein are methods of preparing the pharmaceutical composition and methods of using the same for treating various diseases or disorders such as DVT.
    Type: Application
    Filed: December 6, 2022
    Publication date: October 26, 2023
    Inventors: Steven DINH, Huadong TANG, Wenfei LIANG
  • Compositions and kits for omeprazole suspension
    Patent number: 11771686
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: October 3, 2023
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Zeus Pendon, Steven Dinh
  • COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
    Publication number: 20230270862
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Application
    Filed: March 30, 2023
    Publication date: August 31, 2023
    Inventors: Zeus PENDON, Steven DINH
  • COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
    Publication number: 20230248830
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Application
    Filed: March 30, 2023
    Publication date: August 10, 2023
    Inventors: Zeus PENDON, Steven Dinh
  • COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
    Publication number: 20230233682
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Application
    Filed: March 30, 2023
    Publication date: July 27, 2023
    Inventors: Zeus PENDON, Steven DINH
  • Compositions and kits for Omeprazole suspension
    Patent number: 11633478
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Grant
    Filed: January 14, 2022
    Date of Patent: April 25, 2023
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Zeus Pendon, Steven Dinh
  • Silicone-containing acrylic polymers for transdermal drug delivery compositions
    Patent number: 11427666
    Abstract: Described herein are silicone-containing acrylic polymers useful, for example, in transdermal drug delivery compositions, to methods of making and using them, to transdermal drug delivery compositions comprising them, and to methods of making and using such transdermal drug delivery compositions. The polymers are particular suitable for formulating amine drugs, such as amphetamine, methylphenidate, rivastigmine, paroxetine and clonidine.
    Type: Grant
    Filed: October 3, 2019
    Date of Patent: August 30, 2022
    Assignee: NOVEN PHARMACEUTICALS, INC.
    Inventors: Jun Liao, Jilin Zhang, Puchun Liu, Steven Dinh
  • COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
    Publication number: 20220211852
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Application
    Filed: January 14, 2022
    Publication date: July 7, 2022
    Inventors: Zeus PENDON, Steven DINH
  • COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
    Publication number: 20220031683
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Application
    Filed: August 31, 2021
    Publication date: February 3, 2022
    Inventors: Zeus PENDON, Steven Dinh
  • COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
    Publication number: 20210346363
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Application
    Filed: August 20, 2020
    Publication date: November 11, 2021
    Inventors: Zeus Pendon, Steven Dinh
  • Compositions and kits for omeprazole suspension
    Patent number: 11103492
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Grant
    Filed: September 10, 2020
    Date of Patent: August 31, 2021
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Zeus Pendon, Steven Dinh
  • Compositions and methods for transdermal delivery of tertiary amine drugs
    Patent number: 10987316
    Abstract: Described are transdermal drug delivery systems for the transdermal administration of tertiary amine drugs, such as rivastigmine, fentanyl or rotigotine, comprising a polymer matrix comprising a free base form of the drug and at least one carboxyl group-containing compound. In some embodiments, the systems include a rate-controlling membrane and a skin-contacting face adhesive apart from the polymer matrix.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: April 27, 2021
    Assignee: NOVEN PHARMACEUTICALS, INC.
    Inventors: Jun Liao, Takito Shima, Puchun Liu, Steven Dinh
  • COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
    Publication number: 20210069167
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Application
    Filed: September 10, 2020
    Publication date: March 11, 2021
    Inventors: Zeus Pendon, Steven Dinh
  • SILICONE-CONTAINING ACRYLIC POLYMERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS
    Publication number: 20200277424
    Abstract: Described herein are silicone-containing acrylic polymers useful, for example, in transdermal drug delivery compositions, to methods of making and using them, to transdermal drug delivery compositions comprising them, and to methods of making and using such transdermal drug delivery compositions. The polymers are particular suitable for formulating amine drugs, such as amphetamine, methylphenidate, rivastigmine, paroxetine and clonidine.
    Type: Application
    Filed: October 3, 2019
    Publication date: September 3, 2020
    Applicant: NOVEN PHARMACEUTICALS, INC.
    Inventors: Jun Liao, Jilin Zhang, Puchun Liu, Steven Dinh
  • Compositions and kits for omeprazole suspension
    Patent number: 10751333
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: August 25, 2020
    Assignee: CUTISPHARMA, INC.
    Inventors: Zeus Pendon, Steven Dinh
  • Pressure-sensitive adhesives for transdermal drug delivery
    Patent number: 10406116
    Abstract: Described are pressure-sensitive adhesive polymers (PSAs) useful, for example, for application to the skin, such as in the field of transdermal drug delivery. The PSAs include polar groups modeled on one or more polar portions of skin lipids, which contribute to good skin adhesion properties. Methods of making the PSAs, compositions comprising them, and methods of making and using them also are provided.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: September 10, 2019
    Assignee: NOVEN PHARMACEUTICALS, INC.
    Inventors: Jilin Zhang, Jun Liao, Puchun Liu, Steven Dinh
  • Pressure-sensitive adhesives for transdermal drug delivery
    Patent number: 10406115
    Abstract: Described are pressure-sensitive adhesive polymers (PSAs) useful, for example, for application to the skin, such as in the field of transdermal drug delivery. The PSAs include polar groups modeled on one or more polar portions of skin lipids, which contribute to good skin adhesion properties. Methods of making the PSAs, compositions comprising them, and methods of making and using them also are provided.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: September 10, 2019
    Assignee: NOVEN PHARMACEUTICALS, INC.
    Inventors: Jilin Zhang, Jun Liao, Puchun Liu, Steven Dinh
  • Gastric Retention and Controlled Release Delivery System
    Publication number: 20190216729
    Abstract: The present invention relates to gastric retention delivery systems and controlled release compositions containing a pharmaceutically acceptable active agent and a delivery agent.
    Type: Application
    Filed: December 18, 2017
    Publication date: July 18, 2019
    Inventors: Jun Liao, Puchun Liu, Steven Dinh, Brahma Singh, Shingai Majuru, Prateek N. Bhargava